Unlock instant, AI-driven research and patent intelligence for your innovation.

Levoamlodipine mesylate crystal form, preparation method and use thereof

A kind of technology of levamlodipine and methanesulfonic acid, which is applied in the field of medicine and achieves the effect of high purity

Active Publication Date: 2016-01-13
GUANGDONG XIANQIANG PHARMA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] At present, there is no crystal form report about levamlodipine mesylate at home and abroad. Therefore, it is necessary to study the crystal form of levamlodipine mesylate to provide mesylate with high purity and suitable for making pharmaceutical preparations. Crystal form of levamlodipine acid

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Levoamlodipine mesylate crystal form, preparation method and use thereof
  • Levoamlodipine mesylate crystal form, preparation method and use thereof
  • Levoamlodipine mesylate crystal form, preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Add 30.6 g of levoamlodipine and 250 mL of ethyl acetate into the reaction flask, stir to dissolve, add 8 g of methanesulfonic acid, and stir at 25° C. for 16 hours. Filtered to obtain 38 g of a white solid. The solid was recrystallized with 200 mL of ethyl acetate, cooled and crystallized, filtered, and dried under vacuum to obtain 31 g of off-white solid. The purity determined by HPLC method is 99.6%. The X-diffraction pattern of this crystal form is shown in figure 1 , See the infrared spectrum figure 2 .

Embodiment 2

[0028] Add 30.6 g of levoamlodipine and 250 mL of methanol to the reaction flask, stir to dissolve, add 8 g of methanesulfonic acid, stir at 25° C. for 16 hours, add 200 mL of ethyl acetate crystals, filter, and vacuum dry to obtain 27 g of off-white solids. The purity determined by HPLC method was 99.9%, and its X-diffraction pattern and infrared pattern were similar to those of Example 1.

Embodiment 3

[0030] Add 30.6 g of levoamlodipine and 150 mL of acetone to the reaction flask, add 8 g of methanesulfonic acid after stirring to dissolve, stir at 25° C. for 16 h, add 200 mL of ethyl acetate crystals, filter, and vacuum dry to obtain 25 g of off-white solid. The purity determined by HPLC method was 99.8%, and its X-diffraction pattern and infrared pattern were similar to those in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
optical rotationaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of medicines and in particular relates to a crystal form of levamlodipine mesylate as well as a preparation method and application thereof. The crystal form is characterized in that Cu-Kalpha radiation is used; X-ray diffraction shown by the 2theta angle has characteristic peaks at 11.0+ / -0.2 degrees, 12.5+ / -0.2 degrees, 13.4+ / -0.2 degrees, 14.9+ / -0.2 degrees, 22.0+ / -0.2 degrees and 23.7+ / -0.2 degrees.

Description

Technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to 4S-(-)-3-ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1, 4 -Dihydro-6-methyl-3,5-pyridinedicarboxylate methanesulfonate (levoamlodipine mesylate) crystal form, preparation method and use. Background technique [0002] Amlodipine, whose structural formula is shown in formula 1, is a new generation of calcium ion antagonist. It was developed by Pfizer in 1986 and first listed in the UK in 1990. The product is IstinTabS. Listed in my country in 1993, the product name is Luohuoxi. Amlodipine effectively overcomes the disadvantages of the second-generation calcium ion antagonists diltiazem and nifedipine, which are unstable in lowering blood pressure and have large adverse reactions. Amlodipine is clinically used for the treatment of hypertension and stable angina pectoris. It has the characteristics of remarkable curative effect, stable onset, long time (24-hour...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D211/90C07C303/44C07C309/04A61K31/4422A61P9/12
CPCC07D211/90
Inventor 郑玉春孙晔张志生杜丽丽王雪志彭如清
Owner GUANGDONG XIANQIANG PHARMA